Anne Li Feburary 2nd, 2018
New drugs that activate the immune system to target cancer cells have improved the lives of many patients with cancer. However, immunotherapies are not effective in all patients, and the success of these therapies depends on individual patient factors. A team of Moffitt Cancer Center researchers is trying to find new ways to further enhance the activity of the immune system against cancer. In an article published in the January issue of Cancer Cell, the researchers describe how a new type of immunotherapy drug targeting the protein TIM-3 works to stimulate the immune system.
See original article at: https://www.sciencedaily.com/releases/2018/01/180130123757.htm
Post a comment